Article in Medical Life Sciences News: Uniqsis FlowSyn continuous flow reactor helps simplify scale-up of API batch processes

Arcinova, a Quotient Sciences business, puchased a Uniqsis FlowSyn Continuous Flow Reator to support our drug substance capabilities. The addition of the Uniqsis FlowSyn™ reactor will enable Arcinova to develop and simplify the scale-up of a challenging API batch process. 

To access the full article visit: